MyAverix Finance
SHG · Healthcare
Shanghai Yizhong Pharmaceutical Co Ltd (688091)
Drug Manufacturers - Specialty & Generic
Shanghai Yizhong Pharmaceutical Co Ltd (688091) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $11.87B, P/E ratio is 522.00, net margin is 20.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 688091
Shanghai Yizhong Pharmaceutical Co Ltd (688091) — FAQ
What is Shanghai Yizhong Pharmaceutical Co Ltd's market cap?
Shanghai Yizhong Pharmaceutical Co Ltd (688091) has a reported market cap of $11.87B (data as of 2026-03-29).
What is 688091's P/E ratio?
The price-to-earnings (P/E) ratio for Shanghai Yizhong Pharmaceutical Co Ltd (688091) is 522.00 (data as of 2026-03-29).
Does Shanghai Yizhong Pharmaceutical Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Shanghai Yizhong Pharmaceutical Co Ltd (688091). Check the MyAverix Finance app for the latest dividend data.
What sector is Shanghai Yizhong Pharmaceutical Co Ltd in?
Shanghai Yizhong Pharmaceutical Co Ltd (688091) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 688091 listed on?
688091 is listed on SHG.
What is Shanghai Yizhong Pharmaceutical Co Ltd's net margin?
Shanghai Yizhong Pharmaceutical Co Ltd (688091) reports a net margin of 20.2% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.